Posted on November 28, 2019
With nearly 30 years’ experience in the medicines and medical device industry, Andrew is a highly qualified and skilled business leader and company director, with a strong track record in leadership, strategy, business structuring, growth and delivering financial stability.
This along with Andrew’s nearly twenty years of governance experience in both the private and public sector will bring a depth of knowledge to the ARCS Board as they work to shape the future of the organisation, with a continued focus on their mission of providing education, career pathways, professional development and advocacy to those working in the sector.
In a recent announcement ARCS President, George Papadopoulos, welcomed Andrew and other newly elected members to the Board and thanked outgoing Board members for their contributions to ARCS and the healthcare sector.
For more information on ARCS Australia, please click here.